© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Nimesulide traces its origins back to the 1970s in Italy, where chemists experimented with sulfonanilide compounds for better pain relief. At the time, major anti-inflammatory drugs like aspirin and ibuprofen dominated pain management, but their gastric side effects drove intense research into alternatives. After meticulous refinement, nimesulide entered the European pharmaceutical scene in the mid-1980s, promising to limit common gastrointestinal harms. Its introduction marked a shift—a signal that medical science has never satisfied itself with the status quo. Over decades, researchers documented its effectiveness not just for arthritis, but for a range of inflammatory pain conditions. Nimesulide’s history tells a story of persistent trial, optimism, and a willingness to rethink how we approach pain.
Nimesulide falls under the category of selective COX-2 inhibitors, though not as exclusive as later drugs like celecoxib. Most folks recognize it as a yellowish, slightly bitter powder that takes the form of tablets, suspensions, or topical gels. Global branding plays its part—generics dominate markets under dozens of trade names from Nise to Mesulid. In some countries, physicians prescribe nimesulide for osteoarthritis, fevers, muscle pain, and dental aches. Regulations vary, with tighter controls where evidence points harder toward liver safety concerns. Such differences reflect how societies balance risk and benefit, and how cultures value relief from suffering.
At room temperature, nimesulide presents a moderate melting point just above 140°C. Chemically, it carries the structure 4-nitro-2-phenoxy-methanesulfonanilide. Its molecular formula, C13H12N2O5S, packs together aromatic rings and a nitro group that sets it apart from other painkillers. Nimesulide’s moderate solubility in organic solvents turns manufacturing into a blend of artistry and strict science. It resists dissolution in cold water, forcing pharmaceutical experts to develop special formulations. Chemists know how slight structural tweaks can change both how a drug relieves pain and how it moves through the human body, revealing just how critical those basics of molecular architecture are to real-world medicine.
Nimesulide tablets typically contain 100 mg of active substance, pressed into a compact unit with binding agents and fillers. Labels worldwide must highlight exact dosing, known contraindications (such as liver disease), and risks for children under 12. Expiry periods hover around two to three years if kept away from light and moisture. In European and South Asian packaging, product inserts use bold fonts to flag warnings about the potential for hepatotoxicity and instructions to avoid exceeding recommended durations. These technical specifications may seem dry, yet they anchor safety, equipping patients and healthcare providers with the knowledge needed to handle the drug responsibly.
Industrial production of nimesulide starts with the sulfonation of a phenoxy compound, followed by nitration, and coupling the result with an aniline derivative. This pathway, first mapped out in published patents from the 1970s, requires careful temperature control to keep unwanted byproducts at bay. Auditing the process ensures the finished product meets purity standards—impurities above the tiniest threshold raise red flags both in the plant and in regulatory submissions. Operators in pilot plants and full-scale factories rely on rigorous sampling, making the job a constant back-and-forth between the chemistry lab and the floor.
The unique nitro group in nimesulide’s core allows for targeted reactions, which chemists exploit to make more soluble or longer-lasting derivatives. Sulfonanilide modifications produce new drug candidates, often aiming for fewer side effects or longer half-lives. Sometimes, research teams introduce subtle substitutions on the aromatic ring. These tweaks shift the drug’s metabolism—sometimes slowing hepatic breakdown, sometimes reducing the risk of liver cell stress. Researchers document each change with a battery of tests, knowing that the tiniest shift might make the final drug safer or more effective for millions.
Nimesulide travels the globe under dozens of monikers—Mesulid, Nimulid, Aulin, and more fill shelves in pharmacies from Mumbai to Madrid. Chemical reference texts list synonyms such as N-(4-Nitro-2-phenoxyphenyl)methanesulfonamide. Trademarks and generics share the same molecule, but local laws and branding strategies affect the pill shape, coloring, and even packaging designs. Despite branding, every patient taking nimesulide relies on the common denominator: its recognizable chemical structure and predictable pharmacology.
Any quality drug demands tough rules in both manufacturing and prescribing. Nimesulide’s saga brought that lesson into focus after reports of hepatotoxicity prompted investigations in the late 1990s and early 2000s. Manufacturing plants answer to GMP (Good Manufacturing Practice) frameworks. Operators follow exact protocols for raw material sourcing, parameter checks, lot tracking, and contamination controls. Healthcare workers require ongoing training about signs of adverse effects. Labeling stands as a final defense—patients must see clear, unambiguous instructions. Regulatory agencies such as the European Medicines Agency and Central Drugs Standard Control Organization of India publish guidance documents that get reviewed and updated as science advances.
Doctors reach for nimesulide most often when treating moderate musculoskeletal pain, menstrual cramps, and inflammatory conditions. In many regions, dentists write scripts for it after tooth extraction. Its slightly lower risk of gastric harm compared to some traditional NSAIDs led to widespread use for chronic pain in joints or muscles, at least in settings where alternatives come at greater cost. Human experience shows that not all pain fits typical molds, and the need for drugs like nimesulide points to the complexity of discomfort—and to our shared desire for mobility and peace of mind.
With pressure always mounting to provide safer, better pain relief, labs study nimesulide’s mechanism and metabolism using everything from cell cultures to animal models. Recent advances tap into pharmacogenomic data, searching out why certain people metabolize the drug differently. Studies sometimes pivot to structural relatives, testing if modest changes lower adverse event rates. Real-world surveillance, using broad health databases, tells companies and regulators how nimesulide performs outside controlled trials. Where the science shows risk, research redirects, fueled by ethics as much as economics.
From the late 1990s, liver toxicity became a major focus for nimesulide inquiry. Case reports of jaundice, hepatitis, and more severe outcomes pushed some countries to pull the drug off shelves or restrict its use. Researchers dug into patient records and biochemical markers. Newer work uses in vitro systems to tease out which metabolites stress liver cells and why. This research does more than just flag one product—it sends ripples through pain medication policies and sparks innovation in preclinical safety testing. Toxicologists keep documenting both short-term and chronic outcomes, knowing that patient safety comes before profit or convenience.
No drug with a history as complicated as nimesulide’s stands still. Going forward, its role will depend on how well the medical community sorts specific populations from general cases. Genetics, age, underlying illness—all these factors will guide individualized approaches. Pharmaceutical companies continue to look for substitutes and improved versions, hoping for an ideal balance between relief and risk. There’s real promise in new delivery forms and combinations that might reduce systemic exposure. The story of nimesulide speaks to medicine’s larger struggle: to deliver real relief without compromise, and to stay agile as new knowledge comes to light.
Nimesulide finds a place in many medicine cabinets for one reason—pain doesn’t take a day off. In many parts of the world, doctors hand out nimesulide for everything from backaches and joint stiffness to headaches and period pain. My grandmother’s rheumatologist gave her nimesulide during a winter flare-up, and she still remembers the relief it brought her swollen hands. It works fast, delivering a gentle punch to inflammation, making people mobile again just when they need it most.
Unlike old-school NSAIDs such as ibuprofen or aspirin, nimesulide goes straight for the source of swelling. It blocks the chemicals in charge of pain and warmth—prostaglandins—but works a step later in the body’s cycle. This step-down approach means it knocks down pain with less stomach upset for many. No one enjoys missing work or family gatherings due to burning gastritis.
That said, nothing in medicine comes free of risk. Years back, headlines about nimesulide linked to liver problems brought a wave of worry, especially in Europe and India. People wondered if quick relief was worth the risk. Studies found that misuse or too long a course sometimes strained livers—mostly in those with weak liver function or folks who ignored dosing instructions. Regulatory agencies in Ireland, Spain, and Turkey restricted or banned its sale.
Doctors in other places, like Italy, still prescribe nimesulide because, with proper checks and short courses, its benefits seem to outweigh the risks. For fever in children, many pediatricians stick to acetaminophen or ibuprofen to remain on the safer side. In adults, careful screening and informing the patient about red flags can help avoid rare trouble.
Life doesn’t stop for chronic pain. I’ve watched relatives in rural clinics turn to nimesulide not because it is trendy, but because for some, it hits pain faster than generic pills they’ve tried. Popular anti-inflammatories sometimes upset sensitive stomachs or don’t last long enough. Yet, a few months ago, a friend ignored advice and doubled her nimesulide dose after a tough hike and landed herself with yellowish skin and fatigue—a classic sign that the liver was struggling. Her doctor caught it early, but others haven’t been so lucky.
So, what should we do? Most experts now say: keep it short, keep it low-dose, skip it entirely if liver history clouds your health record. Governments and doctors must keep tabs, run campaigns on safe use, and encourage pharmacists to watch for misuse. Drug companies, for their part, need to push forward with newer painkillers with better safety records—aspiring for something as effective as nimesulide without the same potential for harm.
Pain demands relief, but experience shows that reaching for a bottle is only the start. Good pain management means listening to your body, looking after your liver, taking breaks from pills, and calling for help when something feels wrong. Nimesulide works well for many, but grasping that no shortcut in healing comes without trade-offs keeps us wise, not just pain-free.
Nimesulide comes up often in conversations about nonsteroidal anti-inflammatory drugs, especially outside of the United States. Many people reach for this medication to knock out pain, fever, or swelling. Given how it works by blocking certain enzymes in the body that spark inflammation, this drug often seems like a simple fix. As someone who’s seen friends and family take it for sprains, backaches, or even arthritis flare-ups, I can’t help but notice how quickly people turn to it before checking in with their doctor.
Most folks who’ve taken nimesulide have probably felt it in their stomach first. Upset stomach, nausea, and even bouts of vomiting come up a lot after a few doses. Heartburn creeps in, and some report cramps that won’t quit until the drug wears off. A big meal or milk doesn’t always help, either. Taking it with food sometimes softens the impact, but the risk of a stomach bleed, though rare, gets real if you’re mixing it with other painkillers or drinking alcohol. In my own family, I’ve seen elders blaming spicy food for stomach pain only to learn the medicine played a bigger part.
Rashes and itching don’t sound too scary at first, but with nimesulide, hives and redness can signal an allergy brewing beneath the surface. Sometimes, the skin peels or blisters, which isn’t just uncomfortable—it can be dangerous. These are big red flags and need a visit to the doctor, not just another lotion from the pharmacy.
No side effect has earned nimesulide as much scrutiny as potential liver injury. The liver is on double-duty, filtering what we eat and drink, plus handling medicines like nimesulide. Some studies have shown abnormal liver function tests after short courses, and a few people have ended up with jaundice or even acute liver failure. This risk grows for anyone taking it regularly or mixing it with other meds that tax the liver. That’s why so many countries have put strict rules in place or banned over-the-counter nimesulide altogether.
Dizziness and headaches pop up as people go about their day, making driving home from work or school risky. Some get diarrhea, or worse, they deal with swelling in their feet from fluid retention. These symptoms are easy to miss, but they shouldn’t get brushed off. Any pain medicine messing with the kidneys or heart could pack unexpected trouble, especially for people with long-term health problems like hypertension or kidney disease.
The answer isn’t avoiding pain relief entirely, especially for someone whose work or family life depends on getting through a rough patch. Instead, practical steps help keep people safe—like sticking to the shortest course and lowest dose, and telling healthcare professionals about all medications in the routine, including herbal supplements. Regular blood work paints a better picture before and during treatment.
Global health experts remind us that reading labels and understanding what goes into the body isn’t just common sense—it’s self-preservation. Sharing real stories of side effects, not just clinical jargon, can keep friends and family watchful and wise when reaching for pain relief.
Nimesulide looks like just another over-the-counter pain and fever medicine, especially in some countries where pharmacists hand it out easily. People might grab it for a toothache, joint pain, or a stubborn fever. Coming from a family where the medicine cabinet was often stocked with pain relievers, I've seen older relatives or parents give kids whatever worked for their own pain, thinking one pill fits all. Yet health warnings tend to slip through the cracks, especially when the label claims fast relief.
Doctors and researchers have flagged nimesulide for its impact on the liver. I remember reading studies from India and Europe showing children who took nimesulide sometimes landed in the hospital for liver issues, some severe enough to turn their skin yellow with jaundice. The European Medicines Agency and the World Health Organization have voiced real concern, leading to bans or strict restrictions in several countries. No parent wants to risk serious liver injury just to bring down a child’s fever.
Small kids process drugs differently from adults. Their liver enzymes can’t always keep up, leaving harmful side products to build up. Nimesulide doesn’t seem forgiving with small bodies. Docs have safer alternatives—paracetamol and ibuprofen have well-studied safety records if parents use the right dose.
Seniors often juggle multiple prescriptions, so one more anti-inflammatory might tip the scales. Nimesulide can hike up risks for ulcers, stomach bleeding, and kidney trouble. Add age-related organ slowdown and the chances grow higher. Sitting with my grandfather after he developed stomach bleeding from common painkillers drove home just how fast problems can snowball, especially in older adults who often keep quiet about aches until things get serious.
Italy, Spain, and several other countries have either pulled nimesulide off shelves or only allow its use for a few days, never for kids under 12. India, where the drug remains available, has debated restrictions after pressure from pediatricians. These moves aren’t just hoops for drug makers. They show a growing focus on real-world evidence and keeping the most vulnerable people out of harm’s way.
Doctors urge parents and the elderly to steer clear of nimesulide unless alternatives run out and a health professional supervises every dose. A fever scares parents, but running to the nearest unproven pill can backfire. Instead, ask doctors direct questions and get clear instructions about pain control. Pharmacists can also flag unsafe choices—or at least they should.
Our health system works best with real conversations at every step. Doctors should spell out risks and lay out options that fit each patient’s body and history. Families ought to raise concerns, especially when a prescription feels unfamiliar or a side effect shows up fast. Regulators must keep sifting through new reports and ban drugs outright if evidence stacks up against safety. Everyone deserves medicine that helps, not more problems on top of the pain.
Nimesulide, a painkiller often used for inflammation and fever, gets handed out pretty frequently in many countries. Folks often ask doctors and pharmacists if it's fine to pop nimesulide together with something else they're already taking. People want relief fast, but they also worry about what happens when pills mix, and the reality deserves a closer look.
Combining painkillers seems convenient, especially in flu season or after minor injuries. Many have grown used to reaching for both nimesulide and paracetamol to knock back a bad headache or fever. Mixing them sometimes works, but there’s more to consider than just relief. For example, putting two drugs that strain the liver—nimesulide and paracetamol—on the same plate sends an unkind signal to your body. This duo risks overloading the liver, leading to damage that tends to sneak up slowly.
Blending nimesulide with blood thinners or certain antidepressants stirs up other problems. As someone who’s seen elderly family members struggle to remember a growing medication list, I know how easy it is to overlook small safety details. Blood in the urine, random bruises, or hidden ulcers have a way of showing up on people mixing pills without anyone watching closely. Science backs up these real risks—studies in Europe flagged the combination of NSAIDs like nimesulide and anticoagulants as a setup for internal bleeding, sometimes severe.
Stacking nimesulide on top of other NSAIDs like ibuprofen or aspirin almost always spells trouble for the stomach and intestines. Bleeding, cramps, or worse, a torn gut lining, can follow. None of that shows up right away. The kidneys get no break either; people with high blood pressure or diabetes often need to avoid NSAIDs altogether, and nimesulide isn’t an exception here. I’ve seen patients land in the emergency room because a “simple painkiller” quietly pushed their kidneys over the edge.
One point pharmacists drive home is to never treat that folded-up paper tucked in every medicine box as trash. Warnings aren’t there because of legal fears alone. If a label says to ask about drug interactions, it’s for a reason—patients, especially seniors or those managing chronic illness, can catch a brewing problem just by reading before swallowing. Regular check-ins with healthcare providers go a long way, too. Doctors can look over a medicine list, ask questions nobody has time for at home, and even spot new symptoms early on.
Drug safety rarely boils down to a yes or no answer. Doctors and pharmacists look at the full picture: has someone just started a new medication or do they live with a condition that changes how their body clears drugs? Maybe there’s a better choice entirely, like sticking with paracetamol alone for the flu, or using local treatments for sprains. These discussions matter—not everyone’s organs handle medications in the same way, and age or genetics can shift the balance dramatically.
Staying safe means keeping those lines of communication open, updating each prescription, and treating even the simplest pill as something worth a pause and a second look.
No one likes suffering through pain, and Nimesulide promises fast relief. As an NSAID, it can help beat back the aches, fevers, and discomfort that show up with infection or injury. But there’s a reason doctors across much of the world keep a close eye on who takes it—and why.
Liver failure remains the biggest concern. In my own practice as a pharmacist, I’ve seen the number of calls about yellowing eyes and fatigue spike among people who picked up Nimesulide without proper advice. The drug breaks down in the liver and can spark serious inflammation or even organ failure. Anyone with a history of hepatitis, cirrhosis, or lab tests showing high liver enzymes should steer clear.
Elderly patients, or those under twelve, carry extra risk. Older adults process medicines more slowly; their livers and kidneys just don’t work as efficiently. Nimesulide lingers longer in the body, building to dangerous levels. Kids’ developing organs react unpredictably, too, so most medical authorities recommend other ways to take care of their pain and fever.
I’ve talked with patients who trusted Nimesulide to help their joint pain, only to land back with bleeding ulcers. Anyone with a history of stomach ulcers, bleeding, or inflammatory bowel disease raises the chance of stomach lining damage or life-threatening hemorrhage. Even short courses can trigger complications if the stomach is sensitive from the outset.
NSAIDs have a way of reducing blood flow in the kidneys. People with kidney trouble already often notice swelling, changes in urine, or high blood pressure with repeated use. Blood pressure that can’t be controlled, or a heart history—like a heart attack or stroke—should sound another alarm. Every extra milligram can increase strain on already-weak organs.
Mixing Nimesulide with other drugs like blood thinners, lithium, certain antidepressants, or chronic pain medications piles on risk. Bleeding rises. Liver and kidney stress build. Some patients pick up several medications from various providers and nobody catches the dangerous combinations until after a problem surfaces. Pharmacies and clinics should keep up screening and counseling at every visit.
Pregnant women should stay away. NSAIDs can disrupt fetal blood flow or cause kidney stress in the unborn baby, especially past the twentieth week. Nursing mothers face a similar challenge: even tiny amounts pass through milk, and newborn livers can’t react fast enough to process extra chemicals safely. Most guidelines urge using safer pain relievers instead.
People sorting through pain need more than a warning label. Active community pharmacy programs, digital alerts for drug interactions, and regular bloodwork help catch problems before they get serious. Doctors can lean on safer alternatives like acetaminophen or simple physical therapies when dealing with mild pain. Patients themselves play a role by reading labels, sharing their full health history, and sticking with reviewed prescriptions rather than self-medicating from local shops.
Paying attention to these warnings keeps more folks out of the emergency room. Along with smart prescribing, education, and follow-up, care teams can keep Nimesulide in its place—as a backup, not a first line day-to-day solution.
| Names | |
| Preferred IUPAC name | 4-nitro-2-phenoxymethanesulfonanilide |
| Other names |
Nimegesic Nimule Nimsaid Nimulid Aulin Mesulid |
| Pronunciation | /naɪˈmiː.sjuː.laɪd/ |
| Identifiers | |
| CAS Number | 51803-78-2 |
| Beilstein Reference | 3485165 |
| ChEBI | CHEBI:7575 |
| ChEMBL | CHEMBL646 |
| ChemSpider | 5119 |
| DrugBank | DB04743 |
| ECHA InfoCard | ECHA InfoCard: 100.108.034 |
| EC Number | EC 1.14.99.24 |
| Gmelin Reference | 81852 |
| KEGG | C07329 |
| MeSH | D015153 |
| PubChem CID | 4466 |
| RTECS number | RN9829646 |
| UNII | R1NSC91B1L |
| CompTox Dashboard (EPA) | DTXSID2024339 |
| Properties | |
| Chemical formula | C13H12N2O5S |
| Molar mass | 308.314 g/mol |
| Appearance | Yellow powder. |
| Odor | Odorless |
| Density | 1.21 g/cm³ |
| Solubility in water | Slightly soluble in water |
| log P | 1.62 |
| Vapor pressure | 4.6 x 10^-10 mmHg |
| Acidity (pKa) | 6.5 |
| Basicity (pKb) | 5.34 |
| Magnetic susceptibility (χ) | -81.0×10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.63 |
| Dipole moment | 4.52 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 317.8 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -393.1 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -5877 kJ/mol |
| Pharmacology | |
| ATC code | M01AX17 |
| Hazards | |
| Main hazards | May cause liver damage, gastrointestinal bleeding, kidney impairment, and hypersensitivity reactions. |
| GHS labelling | GHS07, GHS08 |
| Pictograms | NSAIDs", "Analgesics", "Antipyretics |
| Signal word | Warning |
| Hazard statements | H302: Harmful if swallowed. H315: Causes skin irritation. H319: Causes serious eye irritation. H335: May cause respiratory irritation. |
| Precautionary statements | Keep out of reach of children. If swallowed, seek medical advice immediately. Avoid contact with eyes and skin. Do not use if you are allergic to nimesulide or any of the ingredients. Use under medical supervision. Store below 25°C, in a dry place. |
| Flash point | “225.8 °C” |
| Autoignition temperature | 540°C |
| Lethal dose or concentration | LD₅₀ (oral, rat): 980 mg/kg |
| LD50 (median dose) | LD50 (median dose): 940 mg/kg (oral, rat) |
| NIOSH | RG0W9JL6MF |
| PEL (Permissible) | 1 mg/m³ |
| REL (Recommended) | 100 mg every 12 hours |
| IDLH (Immediate danger) | Not established |
| Related compounds | |
| Related compounds |
Nimesulide lysine Nimesulide β-cyclodextrin Nimesulide paracetamol Nimesulide sodium Sulfonanilide |
